This Science News Wire page contains a press release issued by an organization and is provided to you "as is" with little or no review from Science X staff.

Why can Shuyusan treat corticosterone-induced impairment?

September 6th, 2013
Why can Shuyusan treat corticosterone-induced impairment?
5 μg/mL Shuyusan-containing serum reduced Bax expression in the corticosterone-injured SH-SY5Y cells. Credit: Neural Regeneration Research

Synthetic antidepressants present a narrow spectrum and side effects following long-term application. Recently, medical practitioners have shown interest in the use of Chinese medicines for the treatment of diseases and in the adjustment of the human response to stress. Liping Chen and colleagues from Hainan Branch of Chinese PLA General Hospital have found in their preliminary studies that the Chinese herb Shuyusan, whose main constituent is jasminoidin, has been shown to protect SH-SY5Y cells against corticosterone-induced damage.

A recent study reported in the Neural Regeneration Research (Vol. 8, No. 22, 2013) showed that 5 and 30 μg/mL Shuyusan-containing serum elevated the survival rate of SH-SY5Y cells, reduced Bax expression, increased Bcl-2 expression, markedly elevated brain-derived neurotrophic factor mRNA expression, and blocked cell apoptosis. Moreover, the effect of high-dose (30 μg/mL) Shuyusan-containing serum was more remarkable. These findings indicate that Shuyusan-containing serum appears to protect SH-SY5Y cells against corticosterone-induced impairment by adjusting the expression of apoptosis-associated proteins and brain-derived neurotrophic factor.

Provided by Neural Regeneration Research

Citation: Why can Shuyusan treat corticosterone-induced impairment? (2013, September 6) retrieved 29 July 2026 from https://sciencex.com/wire-news/139915314/why-can-shuyusan-treat-corticosterone-induced-impairment.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.